# Your brain on Ozempic

Source: https://www.youtube.com/watch?v=cELpept6Z6Y
Recap page: https://rapidrecap.app/video/cELpept6Z6Y
Generated: 2026-10-01T18:03:58.317+00:00

---
## The Gist

GLP-1 drugs like Ozempic paradoxically reduce the anticipation of a treat in the brain while actually increasing the brain's pleasure response when the treat is consumed. This dual action explains how the medication curbs cravings and points toward potential new treatments for addiction.

## Quick Overview

GLP-1 weight loss drugs like Ozempic change brain function by diminishing the anticipation of a reward while heightening the actual pleasure of tasting it. Scientists discovered this mechanism by administering exenatide to participants and monitoring brain activity while delivering chocolate milk. This specific neurological response reduces wanting while maintaining liking, offering a promising avenue for treating various forms of addiction.

**Key Points:**
- GLP-1 receptor agonists like Ozempic alter brain activity during the consumption and anticipation of treats.
- Researchers tested this effect on four dozen participants by squirting chocolate milk or a tasteless liquid into their mouths during brain scans.
- Participants receiving the GLP-1 drug exenatide showed increased brain reward region activation while actually tasting the chocolate milk compared to a placebo.
- During the moments of anticipation just before tasting the chocolate milk, participants on the GLP-1 drug experienced reduced activity in their brain reward centers.
- This neurological shift indicates that the medication specifically targets and reduces cravings or wanting behavior.
- The findings suggest a promising therapeutic model for addiction, where reward-seeking systems are often overactive while pleasure systems are underactive.

![Screenshot at 0:50: The revelation that GLP-1 drugs reduce brain activity during the anticipation phase of a reward.](https://ss.rapidrecap.app/screens/cELpept6Z6Y/00-00-50.jpg)

**Context:** Scientists are increasingly studying GLP-1 receptor agonists beyond diabetes and weight management to understand their broader neurological impacts on reward processing and addiction pathways.

## Detailed Analysis

Researchers investigating the neurological effects of GLP-1 weight loss drugs discovered a distinct mechanism involving anticipation and consumption. By administering exenatide to four dozen participants and scanning their brains while they tasted chocolate milk, scientists observed that the medication actually increases the brain's reward response during the moment of consumption. However, in the seconds leading up to the taste when participants anticipated the reward, the drug suppressed activity in the brain reward centers. This precise dual effect, decreasing wanting while preserving or enhancing liking, provides a neurological explanation for reduced appetite and opens new possibilities for addiction treatments.

### The Chocolate Milk Experiment

Scientists tracked brain responses to sweet treats under the influence of a GLP-1 drug.

- Researchers scanned the brains of four dozen participants while delivering either tasteless liquid or chocolate milk.
- Participants were given a GLP-1 drug called exenatide to measure changes in their neurological responses.

![Screenshot at 0:09: Brain scan experiment setup involving liquid delivery to participants.](https://ss.rapidrecap.app/screens/cELpept6Z6Y/00-00-09.jpg)

### The Neurological Twist on Liking and Wanting

The drug creates an unexpected contrast between anticipation and consumption.

- Brain reward regions lit up more on the GLP-1 drug during the actual tasting of the chocolate milk than on the placebo.
- During the moments of anticipation right before tasting, participants on the drug experienced reduced activity in their brain reward centers.
- This unique balance reduces the psychological wanting of a reward while maintaining the pleasure of liking it.

![Screenshot at 0:51: Brain activity data showing reduced reward center activation during anticipation.](https://ss.rapidrecap.app/screens/cELpept6Z6Y/00-00-51.jpg)